Keyphrases
Adult Cancer
100%
Adult Life
33%
Age at Diagnosis
33%
Age at Menopause
33%
Age at Treatment
33%
Alkylating Agents
66%
Amenorrhea
100%
Anticancer Treatment
33%
Breast Cancer Survivors
66%
Busulfan
33%
Cancer Survivors
66%
Chemotherapy
100%
Chemotherapy-induced
33%
Chemotherapy-only
33%
Comprehensive Search
33%
Cyclophosphamide
33%
Female Survivors
100%
High Age
33%
High Risk
66%
In Cancer
33%
Late Effects
100%
Methodological Limitations
33%
Old Age
33%
Ovarian Dysfunction
66%
Ovarian Function
100%
Premature Menopause
33%
Procarbazine
66%
Risk Factors
33%
Time-to-treatment
33%
Medicine and Dentistry
Adverse Event
100%
Alkylating Antineoplastic Agent
66%
Amenorrhea
100%
Breast Cancer
66%
Busulfan
33%
Cancer in Young Adults
100%
Cancer Therapy
33%
Cyclophosphamide
33%
Early Menopause
33%
Lifespan
33%
Malignant Neoplasm
66%
Ovary Function
100%
Ovary Insufficiency
66%
Population
33%
Prevalence
66%
Procarbazine
66%
Systematic Review
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Alkylating Agent
40%
Amenorrhea
60%
Breast Cancer
40%
Busulfan
20%
Chemotherapy
100%
Cyclophosphamide
20%
Early Menopause
20%
Malignant Neoplasm
100%
Ovary Insufficiency
40%
Prevalence
40%
Procarbazine
40%
Immunology and Microbiology
Cyclophosphamide
50%
Early Menopause
50%
Lifespan
50%
Ovary Function
100%
Population
50%
Prevalence
100%